Cycloserine

Active ingredient: Cycloserine

In short: Cycloserine is indicated in the treatment of active pulmonary and extrapulmonary tuberculosis (including renal disease) when the causative organisms are susceptible to this drug and when treatment with the primary medications (streptomycin, isoniazid, rifampin, and ethambutol) has proved inadequate.

LabelDr. Reddy’s Laboratories, Inc.
Label updatedJul 31, 2024

What is Cycloserine used for?

Cycloserine is indicated in the treatment

of active pulmonary and extrapulmonary

tuberculosis (including renal disease) when

the causative organisms are susceptible to

this drug and when treatment with the primary

medications (streptomycin, isoniazid, rifampin,

and ethambutol) has proved inadequate. Like

all antituberculosis drugs, cycloserine should be

administered in conjunction with other effective

chemotherapy and not as the sole therapeutic

agent.

Cycloserine may be effective in the treatment

of acute urinary tract infections caused by

susceptible strains of gram-positive and gram-

negative bacteria. Use of cycloserine in these

infections should be considered only when

more conventional therapy has failed and when

the organism has been demonstrated to be

susceptible to the drug

âš  Boxed warning (FDA's strongest warning)

Administration of cycloserine should be discontinued or the dosage reduced if the patient develops allergic dermatitis or symptoms of CNS toxicity, such as convulsions, psychosis, somnolence, depression, confusion,

hyperreflexia, headache, tremor, vertigo paresis, or dysarthria.

The toxicity of cycloserine is closely related to excessive blood levels (above 30 mcg/mL), as determined by high dosage or inadequate renal clearance. The ratio of toxic dose to effective dose in tuberculosis is small.

The risk of convulsions is increased in chronic alcoholics.

Patients should be monitored by hematologic, renal excretion, blood level, and liver function studies.

Cycloserine dosage

Cycloserine is effective orally and is currently administered only by this route. The usual dosage is 500 mg to 1 g daily in divided doses monitored by blood levels.1 The initial adult dosage most frequently given is 250 mg twice

daily at 12-hour intervals for the first 2 weeks. A daily dosage of 1 g should not be exceeded.

Warnings & precautions

Do not take this medicine if: Administration is contraindicated in patients with

any of the following:

• Hypersensitivity to cycloserine

• Epilepsy

• Depression, severe anxiety, or psychosis

• Severe renal insufficiency

• Excessive concurrent use of alcoho

General: Before treatment with cycloserine is initiated, cultures should be taken and the organism’s susceptibility to the drug should be established. In tuberculous infections, the organism’s susceptibility to the other antituberculosis agents in the regimen should also be demonstrated.

Anticonvulsant drugs or sedatives may be effective in controlling symptoms of CNS toxicity, such as convulsions, anxiety, and tremor. Patients receiving more than 500 mg of cycloserine daily should be closely observed for such symptoms. The value of pyridoxine in preventing CNS toxicity from cycloserine has not been proved.

Administration of cycloserine and other antituberculosis drugs has been associated in a few instances with vitamin B 12 and/or folic-

acid deficiency, megaloblastic anemia, and sideroblastic anemia. If evidence of anemia develops during treatment, appropriate studies and therapy should be instituted.

Laboratory Tests: Blood levels should be determined at least weekly for patients with reduced renal function, for individuals receiving a daily dosage of more than 500 mg, and for those showing signs and symptoms suggestive of toxicity. The dosage should be adjusted to keep the blood level below 30 mcg/mL.

Drug Interactions: Concurrent administration of ethionamide has been reported to potentiate neurotoxic side effects.

Alcohol and cycloserine are incompatible, especially during a regimen calling for large doses of the latter. Alcohol increases the possibility and risk of epileptic episodes.

Concurrent administration of isoniazid may result in increased incidence of CNS effects, such as dizziness or drowsiness. …

Cycloserine side effects

Most adverse reactions occurring during therapy with cycloserine involve the nervous system or are manifestations of drug hypersensitivity. The following side effects have been observed in patients receiving cycloserine:

Nervous system symptoms (which appear to be related to higher dosages of the drug, i.e., more than 500 mg daily)

• Convulsions • Drowsiness and somnolence • Headache • Tremor • Dysarthria • Vertigo

• Confusion and disorientation with loss of memory • Psychoses, possibly with suicidal tendencies • Character changes • Hyperirritability • Aggression • Paresis • Hyperreflexia • Paresthesia • Major & minor (localized) clonic seizures • Coma

Cardiovascular: Sudden development of congestive heart failure in patients receiving 1 to 1.5 g of cycloserine daily has been reported.

Allergy (apparently not related to dosage)

Skin rash

Miscellaneous: Elevated serum transaminase, especially in patients with preexisting liver disease

To report SUSPECTED ADVERSE REACTIONS, contact Cerovene, Inc. at 1-833-304-9569 or FDA at 1‑800-FDA-1088 or www.fda.gov/medwatch.

About this medicine

D -Cycloserine, (R)-4-amino-3-isoxazolidinone,

is a broad-spectrum antibiotic that is produced

by a strain of Streptomyces orchidaceus and has

also been synthesized. Cycloserine is a white

to off-white powder that is soluble in water and

stable in alkaline solution. It is rapidly destroyed

at a neutral or acid pH.

Cycloserine has a pH between 5.5 and 6.5 in a

solution containing 100 mg/mL. The molecular

weight of cycloserine is 102.09, and it has an

empirical formula of C 3H6N2O 2 . The structural

formula of cycloserine is as follows:

Each capsule contains cycloserine, 250 mg

(2.45 mmol); D & C Yellow No. 10, F D & C Blue

No. 1, F D & C Red No. 3, F D & C Yellow No.

6, gelatin, iron oxide, talc, and titanium dioxide.

How it works: After oral administration, cycloserine is readily absorbed from the gastrointestinal tract, with peak blood levels occurring in 4 to 8 hours. Blood levels of 25 to 30 mcg/mL can generally be maintained with the usual dosage of 250 mg twice a day, although the relationship of plasma levels to dosage is not always consistent. …

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 8e7e2665-7a3d-3f54-9f92-5fe845f02ef9. Read the full official label on DailyMed.

Related medicines

Amoxicillin Azithromycin Doxycycline Amoxicillin and Clavulanate Cephalexin Valacyclovir Sulfamethoxazole and Trimethoprim Nitrofurantoin